» Articles » PMID: 33790475

A Well Plate-based Multiplexed Platform for Incorporation of Organoids into an Organ-on-a-chip System with a Perfusable Vasculature

Overview
Journal Nat Protoc
Specialties Biology
Pathology
Science
Date 2021 Apr 1
PMID 33790475
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Owing to their high spatiotemporal precision and adaptability to different host cells, organ-on-a-chip systems are showing great promise in drug discovery, developmental biology studies and disease modeling. However, many current micro-engineered biomimetic systems are limited in technological application because of culture media mixing that does not allow direct incorporation of techniques from stem cell biology, such as organoids. Here, we describe a detailed alternative method to cultivate millimeter-scale functional vascularized tissues on a biofabricated platform, termed 'integrated vasculature for assessing dynamic events', that enables facile incorporation of organoid technology. Utilizing the 3D stamping technique with a synthetic polymeric elastomer, a scaffold termed 'AngioTube' is generated with a central microchannel that has the mechanical stability to support a perfusable vascular system and the self-assembly of various parenchymal tissues. We demonstrate an increase in user familiarity and content analysis by situating the scaffold on a footprint of a 96-well plate. Uniquely, the platform can be used for facile connection of two or more tissue compartments in series through a common vasculature. Built-in micropores enable the studies of cell invasion involved in both angiogenesis and metastasis. We describe how this protocol can be applied to create both vascularized cardiac and hepatic tissues, metastatic breast cancer tissue and personalized pancreatic cancer tissue through incorporation of patient-derived organoids. Platform assembly to populating the scaffold with cells of interest into perfusable functional vascularized tissue will require 12-14 d and an additional 4 d if pre-polymer and master molds are needed.

Citing Articles

Vascularised organoids: Recent advances and applications in cancer research.

Zhou R, Brislinger D, Fuchs J, Lyons A, Langthaler S, Hauser C Clin Transl Med. 2025; 15(3):e70258.

PMID: 40045486 PMC: 11882480. DOI: 10.1002/ctm2.70258.


Treatment Response to Oncolytic Virus in Patient-Derived Breast Cancer and Hypopharyngeal Cancer Organoids: Evaluation via a Microfluidics Organ-on-a-Chip System.

Sun Y, Liu J, Zhu L, Huang F, Dong Y, Liu S Bioengineering (Basel). 2025; 12(2).

PMID: 40001666 PMC: 11851931. DOI: 10.3390/bioengineering12020146.


Cardiac organ chip: advances in construction and application.

Li J, Hou H, Li Q, Liu J, Zhao Y, Zhao C Biomater Transl. 2025; 5(4):411-424.

PMID: 39872929 PMC: 11764191. DOI: 10.12336/biomatertransl.2024.04.006.


Advancing 3D Engineered In Vitro Models for Heart Failure Research: Key Features and Considerations.

van Doorn E, Amesz J, Manintveld O, de Groot N, Essers J, Shin S Bioengineering (Basel). 2025; 11(12.

PMID: 39768038 PMC: 11673263. DOI: 10.3390/bioengineering11121220.


Conductive Microfibers Improve Stem Cell-Derived Cardiac Spheroid Maturation.

Gonzalez G, Molley T, LaMontagne E, Balayan A, Holman A, Engler A J Biomed Mater Res A. 2024; 113(1):e37856.

PMID: 39719888 PMC: 11703634. DOI: 10.1002/jbm.a.37856.


References
1.
DiMasi J, Grabowski H, Hansen R . Innovation in the pharmaceutical industry: New estimates of R&D costs. J Health Econ. 2016; 47:20-33. DOI: 10.1016/j.jhealeco.2016.01.012. View

2.
Kinch M, Merkel J . An analysis of FDA-approved drugs for inflammation and autoimmune diseases. Drug Discov Today. 2015; 20(8):920-3. DOI: 10.1016/j.drudis.2015.02.006. View

3.
Ben-David U, Ha G, Tseng Y, Greenwald N, Oh C, Shih J . Patient-derived xenografts undergo mouse-specific tumor evolution. Nat Genet. 2017; 49(11):1567-1575. PMC: 5659952. DOI: 10.1038/ng.3967. View

4.
Cekanova M, Rathore K . Animal models and therapeutic molecular targets of cancer: utility and limitations. Drug Des Devel Ther. 2014; 8:1911-21. PMC: 4206199. DOI: 10.2147/DDDT.S49584. View

5.
Danhof M, de Lange E, Della Pasqua O, Ploeger B, Voskuyl R . Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research. Trends Pharmacol Sci. 2008; 29(4):186-91. DOI: 10.1016/j.tips.2008.01.007. View